EFEMP2: A Potential Drug Target and Biomarker (G30008)

Target Name: EFEMP2

NCBI ID: G30008

EFEMP2: A Potential Drug Target and Biomarker

EFEMP2 (endoplasmic fractional linear model protein 2) is a protein that is expressed in most tissues of the body. It is a key regulator of protein synthesis and has been implicated in a number of cellular processes, including cell growth, apoptosis, and autophagy. In recent years, research has focused on developing drugs that target EFEMP2 to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Drug Targeting

EFEMP2 has emerged as a promising drug target due to its unique biology and the diverse range of diseases it has been associated with. One of the key advantages of EFEMP2 is its expressed status in most tissues, which makes it relatively easy to target. Additionally, its role in multiple cellular processes makes it a likely candidate for drugs that can affect a wide range of diseases.

One of the most promising approaches to targeting EFEMP2 is the use of small molecules that can inhibit its activity. This approach is based on the idea that by reducing EFEMP2's activity, researchers can prevent the regulation of various cellular processes and potentially treat a wide range of diseases.

Biomarker

EFEMP2 has also been identified as a potential biomarker for a number of diseases. Its expression has been observed in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, studies have shown that EFEMP2 is often overexpressed in these diseases, which suggests that it may be a useful biomarker for these conditions.

Role in Disease

EFEMP2 is involved in a wide range of cellular processes that are important for normal tissue growth and development. It plays a key role in the regulation of protein synthesis, which is the process by which cells produce the proteins they need to perform their functions. EFEMP2 helps to ensure that the right amount of protein is produced at the right time, which is essential for the growth and development of tissues.

In addition to its role in protein synthesis, EFEMP2 is also involved in the regulation of cell apoptosis, which is the process by which cells die when they are no longer needed. EFEMP2 has been shown to play a key role in the regulation of cell apoptosis, which may make it an attractive target for drugs that are designed to treat neurodegenerative diseases.

EFEMP2 has also been shown to be involved in the regulation of autophagy, which is the process by which cells break down and recycle their own damaged or unnecessary components. This may be an attractive target for drugs that are designed to treat diseases characterized by the accumulation of dead or damaged cells.

Conclusion

EFEMP2 is a protein that is expressed in most tissues of the body and is involved in a wide range of cellular processes that are important for normal tissue growth and development. Its role in protein synthesis, cell apoptosis, and autophagy makes it a promising candidate for drugs that can treat a variety of diseases. Further research is needed to fully understand the biology of EFEMP2 and to develop effective treatments for the associated diseases.

Protein Name: EGF Containing Fibulin Extracellular Matrix Protein 2

Functions: Plays a crucial role in elastic fiber formation in tissue, and in the formation of ultrastructural connections between elastic laminae and smooth muscle cells in the aorta, therefore participates in terminal differentiation and maturation of smooth muscle cell (SMC) and in the mechanical properties and wall integrity maintenance of the aorta (PubMed:27339457). In addition, is involved in the control of collagen fibril assembly in tissue throught proteolytic activation of LOX leading to cross- linking of collagen and elastin (By similarity). Also promotes ELN coacervation and participates in the deposition of ELN coacervates on to microfibrils but also regulates ELN cross- linking through LOX interaction (PubMed:18973305, PubMed:19570982). Moreover adheres to the cells through heparin binding in a calcium-dependent manner and regulates vascularlar smooth muscle cells proliferation through angiotensin signaling (PubMed:23782690)

More Common Targets